From Data to Dossier: Smart Scale-Up Solutions in Biopharmaceutical Manufacturing

A leading biopharmaceutical company focused on developing innovative solutions in drug development and delivery faced a significant challenge: they needed to accelerate critical scale-up initiatives under tight timelines with limited resources. To overcome this hurdle, they partnered with Sequoia Biotech Consulting, leveraging our expertise to develop an intermediate batch size and conduct essential process development studies and characterization reports in line with their Validation Master Plan.

Additionally, our team created a comprehensive Dossier for Module 3 Sections S.2.2, S.2.3, S.2.4, and S.2.5. This partnership not only addressed the client’s immediate scale-up needs but also enhanced their overall agility, positioning them for long-term success in a rapidly evolving market.

All requested process development, characterization, and PPQ reports were generated and approved on time, demonstrating Sequoia’s commitment to efficiency and quality. The approved reports and data were effectively leveraged to generate the necessary Dossier sections. The project was successfully completed within the scheduled timeline, fully meeting the company’s objective of scaling up